Shareholders Equity: The sum of preferred and common equity items.
Viking Therapeutics, Inc. (VKTX) had Shareholders Equity of $134.06M for the most recently reported fiscal quarter, ending 2023-03-31.
| Income Statement Financials | |
-- |
|
$-19.53M |
|
-- |
|
-- |
|
$20.54M |
|
$-20.54M |
|
$1.01M |
|
$-19.53M |
|
$-19.53M |
|
$-19.53M |
|
$-19.53M |
|
$-19.53M |
|
$-19.53M |
|
$-20.54M |
|
$-20.83M |
|
78.35M |
|
78.35M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$149.47M |
|
-- |
|
$1.43M |
|
$150.90M |
|
$15.65M |
|
-- |
|
$1.18M |
|
$16.83M |
|
$134.06M |
|
$134.06M |
|
|
Shareholders Equity |
$134.06M |
79.32M |
|
| Cash Flow Statement Financials | |
$-24.64M |
|
$2.20M |
|
$4.18M |
|
$36.63M |
|
$18.36M |
|
$-18.27M |
|
$3.57M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.57% |
|
-14.57% |
|
-12.94% |
|
-14.57% |
|
$1.69 |
|
$-0.31 |
|
$-0.31 |
|